The objective of the CIHR is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system. Technologies include biomolecular engineering, modelling and simulation, embedded sensors, miniaturization, advanced materials and microelectronic components. Pharmacology relates to knowledge of the actions of toxins and hazardous chemicals and to the development of specific treatments to prevent these actions.
Treatment includes next generation antibiotics and antivirals.
Improved devices to deliver therapies to sites of infection. Biotechnology will be dominant. Modelling is required. The general CIHR Postdoctoral Fellowship and New Investigators guidelines and eligibility criteria will apply. Please refer to the Grants and Awards Guide on CIHR's website.